Intravenous immunoglobulin in children with streptococcal toxic shock syndrome. - Wikidata - awgldk - TriplyDB

Intravenous immunoglobulin in children with streptococcal toxic shock syndrome.

Intravenous immunoglobulin in children with streptococcal toxic shock syndrome.

http://www.wikidata.org/entity/Q37387611

about

Variability in processes of care and outcomes among children hospitalized with community-acquired pneumonia.Multicenter Cohort Study Comparing U.S. Management of Inpatient Pediatric Immune Thrombocytopenia to Current Treatment Guidelines.Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation The contribution of group A streptococcal virulence determinants to the pathogenesis of sepsis.Adjunct corticosteroids in children hospitalized with community-acquired pneumonia Off-label recombinant factor VIIa use and thrombosis in children: a multi-center cohort study.Comparative effectiveness of pleural drainage procedures for the treatment of complicated pneumonia in childhood Emergence of Streptococcus pyogenes emm102 causing toxic shock syndrome in Southern Taiwan during 2005-2012.Adults with chronic health conditions originating in childhood: inpatient experience in children's hospitals.Accuracy of administrative billing codes to detect urinary tract infection hospitalizations Delayed acyclovir therapy and death among neonates with herpes simplex virus infection.Delayed acyclovir and outcomes of children hospitalized with eczema herpeticum.Extracorporeal therapies in pediatric severe sepsis: findings from the pediatric health-care information system.Bench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspective Charges associated with pediatric head injuries: a five year retrospective review of 41 pediatric hospitals in the US.Health insurance and length of stay for children hospitalized with community-acquired pneumonia.Agents to reduce cytokine storm.Clinical characteristics of children with group A streptococcal toxic shock syndrome admitted to pediatric intensive care units.Invasive group a streptococcal disease: epidemiology, pathogenesis and management.Immunoglobulins in adult sepsis and septic shock.Toxic shock syndrome in Australian children.Impact of Intravenous Immunoglobulin on Survival in Necrotizing Fasciitis With Vasopressor-Dependent Shock: A Propensity Score-Matched Analysis From 130 US Hospitals.Immunotherapy for infectious diseases in haematological immunocompromise.Topical corticosteroids and hospital length of stay in children with eczema herpeticum.Evaluation and Management of Necrotizing Soft Tissue Infections.Socioeconomic Status and Hospitalization Costs for Children with Brain and Spinal Cord Injury.Low mortality from intracranial haemorrhage in paediatric patients with haemophilia.Use of intravenous immunoglobulin in critically ill patients.Use of intravenous immunoglobulin therapy in the treatment of septic shock, in particular severe invasive group A streptococcal disease.Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study.Toxic shock syndrome surveillance in UK children.Editorial commentary: step on the GAS: are we almost there for clindamycin and intravenous immunoglobulin?Toxic shock syndrome: under-recognised and under-treated?Therapeutic targets in necrotizing soft tissue infections.Streptococcal Toxic Shock syndrome.Polyspecific Intravenous Immunoglobulin in Clindamycin-treated Patients With Streptococcal Toxic Shock Syndrome: A Systematic Review and Meta-analysis

P2860

Q30528583-BDB6CCDE-3089-4450-A7A5-F3773C05EBFC Q33430385-D2FBFF48-4536-4833-8EB5-E524538E1756 Q34051146-0A5A16D9-D951-465D-9A2C-4B7EF9054EB7 Q34380098-B95D2EC3-5688-415F-B70A-DA4994B3D812 Q34512999-B4843B3C-C637-4743-86F6-91A8DF3C2CF9 Q34786006-DF571074-8BEA-4F28-9CC9-1341B4B7F36C Q35038706-DF7604E2-338B-48D0-BD7F-E2BE69D71944 Q35069734-8E858102-9C7D-4131-8A81-4AC04A21263A Q35070879-06D82986-95F2-4961-9E5B-196991E87EBC Q35136022-A5AB8A73-8E67-48C4-95E3-0E197FA52100 Q36071193-77C5FC1E-F6D2-46F7-8ED0-0017334CE899 Q36071198-306521D4-BD46-4AFB-A071-72498BC6D8EC Q36267645-AB080797-1A6F-4B8F-882D-C9DC504C9E6E Q36646072-CFD26A0C-E7B4-46D9-8802-013DFE1DAC37 Q36666577-1C35092D-8BD0-40D0-85A3-8CB2A4B6E855 Q37425074-C5C0EE56-DB88-4412-99FB-5EF9A910D51F Q37577684-967FD0C6-93E8-4771-BF73-4BD906D9305D Q37803547-BE345DEF-82CA-4BFC-A567-932ABD578A87 Q38017734-A5F72664-B9C1-4854-B944-DEC0C94F8923 Q38034107-4F610F00-78F4-4748-9A53-28ADDD9AAD1B Q38818505-43273CBC-9F63-417C-99CC-B212FAB6E43D Q39062640-24092FD2-28F6-4FE8-B301-0DA93FD7FFEF Q39215653-8165584E-5FAA-418B-87CA-C75CA41887D5 Q39541512-8F4859B6-A35B-473B-B64E-186F111A7FF9 Q40093740-F005206A-26FB-4695-9C5D-FABB3B47AC0A Q40326560-2C61A1AD-2328-4DBA-B78F-1FD6CA054FD5 Q40902649-181B2A4F-9C29-43C4-B419-8F3E377D175E Q41667356-F71AA302-F8AC-400E-B532-905FFB3F8E28 Q42138228-0E6E96AC-3D7F-4FA7-B899-64C2D951EBBE Q42210564-839313D3-0B98-474F-9E70-FC89D1F590CA Q42216913-E21D79A8-78F5-470A-87DD-E12EF87580D2 Q42734318-700735CE-5C4D-4827-A7AC-241FE38A5228 Q44352193-0F7E634A-AF17-4AB8-8791-12DEE7E73D7F Q48188359-B7C874A4-FD7B-4D43-8D2F-DDCD29DA8B43 Q54501771-676AAA04-2E28-408A-93DA-DD9FC7586BBB Q57462312-AAD1E058-7D77-47EB-BD1B-E22FB27B12A4

P2860

Intravenous immunoglobulin in children with streptococcal toxic shock syndrome.

http://www.wikidata.org/entity/Q37387611

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Intravenous immunoglobulin in children with streptococcal toxic shock syndrome.

@en

Intravenous immunoglobulin in children with streptococcal toxic shock syndrome.

@nl

type

label

Intravenous immunoglobulin in children with streptococcal toxic shock syndrome.

@en

Intravenous immunoglobulin in children with streptococcal toxic shock syndrome.

@nl

prefLabel

Intravenous immunoglobulin in children with streptococcal toxic shock syndrome.

@en

Intravenous immunoglobulin in children with streptococcal toxic shock syndrome.

@nl

P1433

Q37387611-126855B7-F502-46CF-BE1D-24186AF8D583

P1476

Q37387611-270E87DD-6651-41B5-91D4-3B1753109266

P2093

Q37387611-5CD264E3-2527-4253-80E5-03DFE50BAAA0

Q37387611-9A7F356A-7EB3-4FBF-AE9E-50B88A26008F

Q37387611-A8E5491B-F8DC-477B-B520-5BA475170A0B

Q37387611-B6D5A00D-88AC-408F-8CBE-947142AB6EDF

P2860

Q37387611-083257D5-1D60-4CD0-98A2-2F5F4E3E93D4

Q37387611-0BB7CC0C-19D8-4650-AD2E-F2A979DE7B1F

Q37387611-1D2CB770-78BA-4CB2-B93E-0F2C260DE424

Q37387611-1D75087D-F5FD-4E7D-8EEA-51599A646212

Q37387611-3651D3D2-BBD0-4193-AAD5-C1970D824940

Q37387611-3CF4F946-AEDC-4146-8E0A-CFF97D54F66E

Q37387611-43A3BEE9-89EA-432B-9297-960A8BFF6CED

Q37387611-4A1CF9FF-0EF8-4E14-B723-5C367AADADB4

Q37387611-501CD00C-189F-4E2B-B190-103709989A0C

Q37387611-628AC2D1-E8E7-4DE9-97CC-773286DD437D

P304

Q37387611-B742F04D-847A-48ED-B569-85EB0AFE6119

P31

Q37387611-09869F7D-98AF-4398-909D-6FCED5AE8B11

P356

Q37387611-71525F99-D2A8-4125-87F9-0310331D938F

P407

Q37387611-605E51B2-F552-4534-9F23-D630278F931D

P433

Q37387611-F9C6A9B4-2F35-40E4-85CD-982D86968224

P478

Q37387611-64455986-6F60-47E6-8580-D967C100361A

P50

Q37387611-C2C39A33-A013-4E33-99C0-7EC6BE36DB81

P577

Q37387611-A89BD4A3-ED1D-473A-86F8-C7B61239391B

P5875

Q37387611-AC5AC796-BE2A-46F3-9EF0-29510DB46A31

P698

Q37387611-EF95C669-1409-495A-8286-0404A92DBDFC

P932

Q37387611-A04175B1-A852-4227-91A2-5D003FD6F04C

P356

P1433

Clinical Infectious Diseases

P1476

Intravenous immunoglobulin in children with streptococcal toxic shock syndrome.

@en

P2093

Anupama Subramony

http://www.w3.org/2001/XMLSchema#string

James E Levin

http://www.w3.org/2001/XMLSchema#string

Matthew Hall

http://www.w3.org/2001/XMLSchema#string

Raj Srivastava

http://www.w3.org/2001/XMLSchema#string

P2860

Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment

Varicella disease after introduction of varicella vaccine in the United States, 1995-2000

Decline in mortality due to varicella after implementation of varicella vaccination in the United States

Opsonic antibodies to the surface M protein of group A streptococci in pooled normal immunoglobulins (IVIG): potential impact on the clinical efficacy of IVIG therapy for severe invasive group A streptococcal infections.

Intravenous immunoglobulin as adjunctive treatment for streptococcal toxic shock syndrome associated with necrotizing fasciitis: case report and review.

A simulation study of the number of events per variable in logistic regression analysis.

Toxic shock syndrome in children: epidemiology, pathogenesis, and management.

A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods.

Indications for propensity scores and review of their use in pharmacoepidemiology.

Principles for modeling propensity scores in medical research: a systematic literature review.

P304

1369-1376

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/606048

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26855218

http://www.w3.org/2001/XMLSchema#string

P698

19788359

http://www.w3.org/2001/XMLSchema#string

P932

2761980

http://www.w3.org/2001/XMLSchema#string